1. Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables
   Faruk Tas et al, 2015, Biomedicine & Pharmacotherapy CrossRef
2. Quantitative proteome analysis of plasma microparticles for the characterization of HCV‐induced hepatic cirrhosis and hepatocellular carcinoma
   Raghda Saad Zaghloul Taleb et al, 2017, PROTEOMICS – Clinical Applications CrossRef
3. Association of annexin A2 with cancer development (Review)
   XIAO-HENG XU et al, 2015, Oncology Reports CrossRef
4. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma
   Haijian Zhang et al, 2015, Tumor Biology CrossRef
5. Biosensor-based early diagnosis of hepatic cancer
   Nikita Sehgal et al, 2022, Biosensor Based Advanced Cancer Diagnostics CrossRef
6. Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area
   K Sideras et al, 2015, British Journal of Cancer CrossRef
7. Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma
   Shu-Wei Huang et al, 2021, Journal of Clinical Medicine CrossRef
8. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma
   Nevine El-Abd et al, 2016, Tumor Biology CrossRef
9. Assessment of the diagnostic role of annexin A2 (ANXA2) and insulin-like growth factor-1 as serum markers for hepatocellular carcinoma
   Dalia H. Abou-Elela et al, 2016, Egyptian Liver Journal CrossRef